Last reviewed · How we verify
NCT05164029
The Clinical Cohort Study of Reproductive Health
trial testing Completion questionnaires/providing biological samples in Fertility Disorders in 3,000 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | Women's Hospital School Of Medicine Zhejiang University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 3,000 |
| Start date | 1 January 2022 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 December 2024 |
Drugs / interventions tested
- Completion questionnaires/providing biological samples
Conditions studied
- Fertility Disorders — all drugs for Fertility Disorders →
- Assisted Reproductive Technology — all drugs for Assisted Reproductive Technology →
- Offspring Health — all drugs for Offspring Health →
Sponsor
Women's Hospital School Of Medicine Zhejiang University
Who can join
Adults 20 to 55, any sex, with Fertility Disorders or Assisted Reproductive Technology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will conduct a multicenter prospective clinical cohort study to collect comprehensive health information and essential specimens from pre-pregnancy to postpartum offspring development. We will combine the reproductive medicine with the big data technologies and cloud computing to explore the key factors which will induce the occurrence the reproductive disorders and effect the health of women and offspring. Based on the discovery of the cohort study, we will construct a prediction model for improvement of ART，optimizing the effectiveness and safety of ART.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05164029
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Completion questionnaires/providing biological samples
Trials testing the same drug.
- NCT04065945 — Epigenetic Safety of Assisted Reproductive Technology · unknown
Other recruiting trials for Fertility Disorders
Currently open trials in the same condition.
- NCT07017972 — Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model · recruiting
- NCT06928337 — Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. · recruiting
- NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
- NCT04663971 — Fertility and Pregnancy After Surgery IBD Audit · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
Other Women's Hospital School Of Medicine Zhejiang University trials
Trials by the same sponsor.
- NCT07369986 — Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer · Phase 2 · not yet recruiting
- NCT07244965 — Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervica · Phase 2 · not yet recruiting
- NCT06561308 — Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer · Phase 2 · recruiting
- NCT07106853 — Prenatal Cell-free DNA Screening in Pregnancies With Diverse Genetic Risk Profiles Utilizing Targeted and Whole-exome Se · not yet recruiting
- NCT07082530 — A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05164029 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Women's Hospital School Of Medicine Zhejiang University
- Last refreshed: 20 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05164029.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing